-
1
-
-
0035101145
-
Cellular and molecular pharmacology of antiestrogen action and resistance
-
Clark RB, Leonessa F, Welch JN and Skaar TC: Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev 53: 25-71, 2005.
-
(2005)
Pharmacol Rev
, vol.53
, pp. 25-71
-
-
Clark, R.B.1
Leonessa, F.2
Welch, J.N.3
Skaar, T.C.4
-
2
-
-
10744230036
-
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
-
Clarke RB, Liu MC, Bouker KB, Gu Z-P, Lee RY, Zhu Y-L, Shaar TC, Gomez B, O'Brien K, Wang Y and Hilakivi-Clarke LA: Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 22: 7316-7339, 2003.
-
(2003)
Oncogene
, vol.22
, pp. 7316-7339
-
-
Clarke, R.B.1
Liu, M.C.2
Bouker, K.B.3
Gu, Z.-P.4
Lee, R.Y.5
Zhu, Y.-L.6
Shaar, T.C.7
Gomez, B.8
O'Brien, K.9
Wang, Y.10
Hilakivi-Clarke, L.A.11
-
3
-
-
0034667395
-
Inhibition of HER2/neu (ERB-B2) and mitogen-activated protein kinases enhances tamoxifen action against HER-2 overexpressing, tamoxifen-resistant breast cancer cells
-
Kurokawa H, Lenferink AE, Simpson JF, Pisacane PI, Sliwkowske MX, Forbes JT and Arteaga CL: Inhibition of HER2/neu (ERB-B2) and mitogen-activated protein kinases enhances tamoxifen action against HER-2 overexpressing, tamoxifen-resistant breast cancer cells. Cancer Res 60: 5887-5894, 2000.
-
(2000)
Cancer Res
, vol.60
, pp. 5887-5894
-
-
Kurokawa, H.1
Lenferink, A.E.2
Simpson, J.F.3
Pisacane, P.I.4
Sliwkowske, M.X.5
Forbes, J.T.6
Arteaga, C.L.7
-
4
-
-
0029662337
-
C-ERB-B2 overexpression decreases the benefit of adjuvant tamoxifen
-
Carlomagno C, Perrone F, Gallo C, De Laurentitis M, Layria R, Morabito A, Pettinato G, Panico l, D'Antonio A, Bianco AR and De Placido S: C-ERB-B2 overexpression decreases the benefit of adjuvant tamoxifen. J Clin Oncol 14: 2702-2708, 1996.
-
(1996)
J Clin Oncol
, vol.14
, pp. 2702-2708
-
-
Carlomagno, C.1
Perrone, F.2
Gallo, C.3
De Laurentitis, M.4
Layria, R.5
Morabito, A.6
Pettinato, G.7
Panico, L.8
D'Antonio, A.9
Bianco, A.R.10
De Placido, S.11
-
5
-
-
0025695815
-
Wilms' tumor locus on 11p13 defined by multiple CpG island-associated transcripts
-
Bonetta L, Kuehn SE, Huang A, Law DJ, Kalikin LM, Koi M, Reeve AE, Brownstein BH, Yeger H and Williams BR: Wilms' tumor locus on 11p13 defined by multiple CpG island-associated transcripts. Science 250: 994-997, 1990.
-
(1990)
Science
, vol.250
, pp. 994-997
-
-
Bonetta, L.1
Kuehn, S.E.2
Huang, A.3
Law, D.J.4
Kalikin, L.M.5
Koi, M.6
Reeve, A.E.7
Brownstein, B.H.8
Yeger, H.9
Williams, B.R.10
-
6
-
-
0025099787
-
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
-
Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H and Lewis WH: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520, 1990.
-
(1990)
Cell
, vol.60
, pp. 509-520
-
-
Call, K.M.1
Glaser, T.2
Ito, C.Y.3
Buckler, A.J.4
Pelletier, J.5
Haber, D.A.6
Rose, E.A.7
Kral, A.8
Yeger, H.9
Lewis, W.H.10
-
7
-
-
0025098654
-
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
-
Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH and Bruns GA: Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778, 1990. (Pubitemid 120028613)
-
(1990)
Nature
, vol.343
, Issue.6260
, pp. 774-778
-
-
Gessler, M.1
Poustka, A.2
Cavenee, W.3
Neve, R.L.4
Orkin, S.H.5
Bruns, G.A.P.6
-
9
-
-
0035835816
-
Wilms' tumor and the WT1 gene
-
Lee SB and Haber DA: Wilms' tumor and the WT1 gene. Exp. Cell Res 264: 74-99, 2001.
-
(2001)
Exp. Cell Res
, vol.264
, pp. 74-99
-
-
Lee, S.B.1
Haber, D.A.2
-
10
-
-
0030891372
-
A clinical overview of WT1 gene mutations
-
Little M and Wells C: A clinical overview of WT1 gene mutations. Hum Mutat 9: 209-225, 1997.
-
(1997)
Hum Mutat
, vol.9
, pp. 209-225
-
-
Little, M.1
Wells, C.2
-
11
-
-
0031048878
-
Aberrant overexpression of the Wilms' tumor gene (WT1) in human leukemia
-
Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, Oka Y, Miyake S, Tamaki H, Oji Y, Yamagami T, Tatekawa T, Soma T, Kishimoto T and Sugiyama H: Aberrant overexpression of the Wilms' tumor gene (WT1) in human leukemia. Blood 89: 1405-1412, 1997.
-
(1997)
Blood
, vol.89
, pp. 1405-1412
-
-
Inoue, K.1
Ogawa, H.2
Sonoda, Y.3
Kimura, T.4
Sakabe, H.5
Oka, Y.6
Miyake, S.7
Tamaki, H.8
Oji, Y.9
Yamagami, T.10
Tatekawa, T.11
Soma, T.12
Kishimoto, T.13
Sugiyama, H.14
-
12
-
-
0037143087
-
Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers
-
Oji Y, Miyoshi S, Maeda H, Hayashi S, Tamaki H, Nakatsuka S, Yao M, Takahashi E, Nakano Y, Hirabayashi H, Shintani Y, Oka Y, Tsuboi A, Hosen N, Asada M, Fujioka T, Murakami M, Kanato K, Motomura M, Kim EH, Kawakami M, Ikegame K, Ogawa H, Aozasa K, Kawase I and Sugiyama H: Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer 100: 297-303, 2002.
-
(2002)
Int J Cancer
, vol.100
, pp. 297-303
-
-
Oji, Y.1
Miyoshi, S.2
Maeda, H.3
Hayashi, S.4
Tamaki, H.5
Nakatsuka, S.6
Yao, M.7
Takahashi, E.8
Nakano, Y.9
Hirabayashi, H.10
Shintani, Y.11
Oka, Y.12
Tsuboi, A.13
Hosen, N.14
Asada, M.15
Fujioka, T.16
Murakami, M.17
Kanato, K.18
Motomura, M.19
Kim, E.H.20
Kawakami, M.21
Ikegame, K.22
Ogawa, H.23
Aozasa, K.24
Kawase, I.25
Sugiyama, H.26
more..
-
13
-
-
0030759827
-
Altered expression of the WT1 Wilms' tumor suppressor gene in human breast cancer
-
Silberstein GB, Horn KV, Strickland P, Roberts CT Jr. and Daniel CW: Altered expression of the WT1 Wilms' tumor suppressor gene in human breast cancer. Proc Natl Acad Sci USA 94: 8132-8137, 1997.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 8132-8137
-
-
Silberstein, G.B.1
Horn, K.V.2
Strickland, P.3
Roberts Jr., C.T.4
Daniel, C.W.5
-
14
-
-
0035117177
-
Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation
-
Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D and Sukumar S: Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res 61: 921-925, 2001.
-
(2001)
Cancer Res
, vol.61
, pp. 921-925
-
-
Loeb, D.M.1
Evron, E.2
Patel, C.B.3
Sharma, P.M.4
Niranjan, B.5
Buluwela, L.6
Weitzman, S.A.7
Korz, D.8
Sukumar, S.9
-
15
-
-
0036091359
-
High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients
-
Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, Sugiyama H and Noguchi S: High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 8: 1167-1171, 2002. (Pubitemid 34517654)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.5
, pp. 1167-1171
-
-
Miyoshi, Y.1
Ando, A.2
Egawa, C.3
Taguchi, T.4
Tamaki, Y.5
Tamaki, H.6
Sugiyama, H.7
Noguchi, S.8
-
16
-
-
77949448448
-
The Wilms' tumor suppressor WT1 A-isoform induces estrogen independent growth and antiestrogen resistance in ER-positive breast cancer MCF7 cells
-
Wang L and Wang Z-Y: The Wilms' tumor suppressor WT1 A-isoform induces estrogen independent growth and antiestrogen resistance in ER-positive breast cancer MCF7 cells. Oncol Rep 23: 1109-1117, 2010.
-
(2010)
Oncol Rep
, vol.23
, pp. 1109-1117
-
-
Wang, L.1
Wang, Z.-Y.2
-
17
-
-
11244250660
-
Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: New opportunities for therapy
-
DOI 10.1677/erc.1.00778
-
Nicholson RI, Staka C, Boyns F, Hutcheson IR and Gee JMW: Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy. Endocr Relat Cancer 11: 623-641, 2004. (Pubitemid 40065542)
-
(2004)
Endocrine-Related Cancer
, vol.11
, Issue.4
, pp. 623-641
-
-
Nicholson, R.I.1
Staka, C.2
Boyns, F.3
Hutcheson, I.R.4
Gee, J.M.W.5
-
18
-
-
0034790009
-
Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer
-
Nicholson RI, Hutcheson IR, Harper ME, Knowlden JM, Barrow D, McClelland RA, Jones HE, Wakeling AE and Gee JMW: Modulation of epidermal growth factor receptor In endocrine-resistant, oestrogen receptor-positive breast cancer. Endocr Relat Cancer 8: 175-182, 2001.
-
(2001)
Endocr Relat Cancer
, vol.8
, pp. 175-182
-
-
Nicholson, R.I.1
Hutcheson, I.R.2
Harper, M.E.3
Knowlden, J.M.4
Barrow, D.5
McClelland, R.A.6
Jones, H.E.7
Wakeling, A.E.8
Gee, J.M.W.9
-
19
-
-
42049121934
-
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance
-
Grazia A, Wiechmann L, Osborne CK and Schiff R: Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance. Endocr Rev 29: 217-233, 2008.
-
(2008)
Endocr Rev
, vol.29
, pp. 217-233
-
-
Grazia, A.1
Wiechmann, L.2
Osborne, C.K.3
Schiff, R.4
-
20
-
-
0020040727
-
Effects of endocrine therapy on steroid-receptor content of breast cancer
-
Taylor R, Powles T, Humphreys J, Bettelheim R, Dowsett M, Casey A, Neville A and Coombes R: Effects of endocrine therapy on steroid-receptor content of breast cancer. Br J Cancer 45: 80-84, 1982.
-
(1982)
Br J Cancer
, vol.45
, pp. 80-84
-
-
Taylor, R.1
Powles, T.2
Humphreys, J.3
Bettelheim, R.4
Dowsett, M.5
Casey, A.6
Neville, A.7
Coombes, R.8
-
21
-
-
34247579714
-
A tumor suppressor and oncogene: The WT1 story
-
DOI 10.1038/sj.leu.2404624, PII 2404624
-
Yang L, Han Y, Saiz FS and Minden MD: A tumor suppressor and oncogene: the WT1 story. Leukemia 21: 868-876, 2007. (Pubitemid 46672061)
-
(2007)
Leukemia
, vol.21
, Issue.5
, pp. 868-876
-
-
Yang, L.1
Han, Y.2
Saurez Saiz, F.3
Minden, M.D.4
-
22
-
-
0027286309
-
The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains
-
Wang ZY, Qiu QQ and Deuel TF: The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J Bio Chem 268: 9172-9175, 1993.
-
(1993)
J Bio Chem
, vol.268
, pp. 9172-9175
-
-
Wang, Z.Y.1
Qiu, Q.Q.2
Deuel, T.F.3
-
23
-
-
77949484047
-
The Wilms' tumor gene product WT1 mediates the down-regulation of the rat epidermal growth factor receptor by nerve growth factor in PC12 cells
-
Liu XW, Gong LJ, Guo LY, Katagiri Y, Jiang H, Wang ZY, Johnson AC and Guroff G: The Wilms' tumor gene product WT1 mediates the down-regulation of the rat epidermal growth factor receptor by nerve growth factor in PC12 cells. J Bio Chem 273: 27047-27050, 1998.
-
(1998)
J Bio Chem
, vol.273
, pp. 27047-27050
-
-
Liu, X.W.1
Gong, L.J.2
Guo, L.Y.3
Katagiri, Y.4
Jiang, H.5
Wang, Z.Y.6
Johnson, A.C.7
Guroff, G.8
-
24
-
-
4644244293
-
Transcriptional activation of c-myc proto-oncogene by WT1 protein
-
DOI 10.1038/sj.onc.1207609
-
Han Y, San-Marina S, Liu J and Minden MD: Transcriptional activation of c-myc proto-oncogene by WT1 protein. Oncogene 23: 6933-6941, 2004. (Pubitemid 39279994)
-
(2004)
Oncogene
, vol.23
, Issue.41
, pp. 6933-6941
-
-
Han, Y.1
San-Marina, S.2
Liu, J.3
Minden, M.D.4
-
25
-
-
0028844582
-
Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1
-
Hewitt SM, Hamada S, McDonnell TJ, Rauscher III FJ and Saunders GF: Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res 55: 5386-5389, 1995.
-
(1995)
Cancer Res
, vol.55
, pp. 5386-5389
-
-
Hewitt, S.M.1
Hamada, S.2
McDonnell, T.J.3
Rauscher III, F.J.4
Saunders, G.F.5
-
26
-
-
0029102956
-
WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis
-
Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re GG, Garvin AJ, Rosner MR and Haber DA: WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14: 4662-4675, 1995.
-
(1995)
EMBO J
, vol.14
, pp. 4662-4675
-
-
Englert, C.1
Hou, X.2
Maheswaran, S.3
Bennett, P.4
Ngwu, C.5
Re, G.G.6
Garvin, A.J.7
Rosner, M.R.8
Haber, D.A.9
-
28
-
-
0023371106
-
Human HER2 (neu) promoter: Evidence for multiple mechanisms for transcriptional initiation
-
Tal M, King CR, Kraus MH, Ullrich A, Schlessinger J and Givollt D: Human HER2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiation. Mol Cell Biol 7: 2597-2601, 1987.
-
(1987)
Mol Cell Biol
, vol.7
, pp. 2597-2601
-
-
Tal, M.1
King, C.R.2
Kraus, M.H.3
Ullrich, A.4
Schlessinger, J.5
Givollt, D.6
-
29
-
-
52449108275
-
Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-α expression in breast cancer cells
-
Han, YQ, Lin Y, Suarez-Saiz F, San-Matina S, Cui J and Minden MD: Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-α expression in breast cancer cells. Mol Cancer Res 6: 1347-1355, 2008.
-
(2008)
Mol Cancer Res
, vol.6
, pp. 1347-1355
-
-
Han, Y.Q.1
Lin, Y.2
Suarez-Saiz, F.3
San-Matina, S.4
Cui, J.5
Minden, M.D.6
-
30
-
-
34249048667
-
Isoforms of Wilms' tumor suppressor (WT1) have distinct effects on mammary epithelial cells
-
Simpson LA, Thompson KA and Loeb DM: Isoforms of Wilms' tumor suppressor (WT1) have distinct effects on mammary epithelial cells. Oncogene 26: 3423-3430, 2007.
-
(2007)
Oncogene
, vol.26
, pp. 3423-3430
-
-
Simpson, L.A.1
Thompson, K.A.2
Loeb, D.M.3
|